4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-16-142026
Director sold 7,500 shares at $19.13 ($143,475)
- Director acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
KUEBLER CHRISTOPHER A · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-09-15 | Exercise or conversion : show line 1 in the form | +15,000 | 35,000 | D | ||
| 2016-09-16 | Sale : show line 2 in the form | −7,500 | $19.13 | $143,475 | 27,500 | D |
| Open-market sales · 7,500 sh · avg $19.13 · $143,475 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2016-09-15 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −15,000 | 15,000 | 0 | D |
Loading xslF345X03/doc4.xml…